Clarifying the Differences in Orphan Drug Designation Between the EMA & FDA

Time: 9:30 am
day: Day Two


  • Highlight the key strategic differences between the two bodies for success in gaining Orphan drug designations
  • Explore the main incentives related to Orphan designations
  • Understand the concept of similarity for Orphan drug exclusivity